DARA Pharma Group will develop MODULINE isolators under the agreement with GETINGE - LACALHENE

In 2014, DARA and GETINGE - LACALHENE reached an agreement to develop and manufacture a modular, flexible, and standardized concept of aseptic filling lines in isolator. That is when Moduline product range was born. 

After having defined, developed, and manufactured several machines, and achieved a product that was validated by the pharmaceutical industry, both companies have moved further in their alliance. GETINGE - LACALHENE has transferred DARA Pharma Group the required technological know-how to produce and assemble these isolators that will now be done at DARA's production plant in Barcelona. The objective of this agreement is to optimize costs and, especially, reduce the delivery time of the fully integrated lines. 

The design of the isolators and VHP bio-decontamination cycles, were carried by this Swedish-French company at their facilities Vendôme (France). The same staff who supervised these procedures will also oversee validating and adapting the equipment and the cycles of bio-decontamination to each project specifications. 

Within this new frame of cooperation, the supply, production, and assembly of the isolators will be in the hands of DARA Pharma Group. Thus, and following the quality standards required by the industry, we will guarantee its perfect adaptation and integration in the filling lines that DARA has been providing for 25 years now.  

MODULINE, a cutting-edge technology product, predesigned and prevalidated, allows us to reduce the delivery time for aseptic filling lines in isolator to a period that goes from 8 to 12 months. Therefore, DARA and COOLVACUUM can deliver these integrated solutions in half the time compared to their competitors, being able to integrate and manufacture the fully integrated lines as well.